For the past year, Save Your Skin Foundation has been working with ocular melanoma (OM) survivor and advocate Nigel Deacon, to improve OM patient care across the country. Together we created a survey and resulting report in order to gain insight into the Canadian OM...
At this time of year, I like to personally thank all of our patients, caregivers, family and friends for their ongoing support. We've made great progress this year in improving psycho-social care and treatment options for patients, especially those in the adjuvant setting. We could...
We are happy to announce the launch of an informative website about clinical trials by another of our supporting partners. F. Hoffmann-La Roche Ltd. has put together a website called ForPatients, which includes a search tool for finding clinical trials in various cancer indications, plus...
Join us for this free webinar, which reviews the latest news and clinical data related to melanoma treatment in the adjuvant setting, as presented in the 2018 conference season. 'Adjuvant' refers to patients with a stage II or stage III diagnosis. The majority of adjuvant patients typically undergo...
On September 26, 2018, you may have seen a special insert in the paper version of the National Post across the country, featuring eight pages of informative articles about immunotherapy, an innovative treatment proving successful in several cancer indications. This special content is the result...
In September 2018, Save Your Skin Foundation (SYSF) conducted an anonymous survey of melanoma patients in the adjuvant setting (diagnosed at a stage lesser than stage IV). This survey, titled "Melanoma Treatments in the Adjuvant Setting," was open globally, and we received responses from all...
